Commonwealth Equity Services’s GALENA BIOPHARMA INC COM RXII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-42,715
| Closed | -$15K | – | 2414 |
|
|
2016
Q3 | $15K | Sell |
42,715
-300
| -0.7% | -$105 | ﹤0.01% | 2228 |
|
|
2016
Q2 | $20K | Sell |
43,015
-3,100
| -7% | -$1.44K | ﹤0.01% | 2201 |
|
|
2016
Q1 | $63K | Buy |
46,115
+7,000
| +18% | +$9.56K | ﹤0.01% | 2114 |
|
|
2015
Q4 | $57K | Sell |
39,115
-400
| -1% | -$583 | ﹤0.01% | 2091 |
|
|
2015
Q3 | $62K | Buy |
39,515
+1,075
| +3% | +$1.69K | ﹤0.01% | 2039 |
|
|
2015
Q2 | $65K | Buy |
38,440
+21,300
| +124% | +$36K | ﹤0.01% | 2116 |
|
|
2015
Q1 | $24K | Buy |
17,140
+3,000
| +21% | +$4.2K | ﹤0.01% | 2152 |
|
|
2014
Q4 | $21K | Sell |
14,140
-1,289
| -8% | -$1.91K | ﹤0.01% | 2066 |
|
|
2014
Q3 | $32K | Hold |
15,429
| – | – | ﹤0.01% | 2035 |
|
|
2014
Q2 | $47K | Sell |
15,429
-2,711
| -15% | -$8.26K | ﹤0.01% | 1992 |
|
|
2014
Q1 | $45K | Buy |
18,140
+2,726
| +18% | +$6.76K | ﹤0.01% | 1949 |
|
|
2013
Q4 | $76K | Buy |
+15,414
| New | +$76K | ﹤0.01% | 1846 |
|
|
2013
Q3 | – | Sell |
-12,813
| Closed | -$28K | – | 1962 |
|
|
2013
Q2 | $28K | Buy |
+12,813
| New | +$28K | ﹤0.01% | 1769 |
|
Commonwealth Equity Services's RXII Position: Q4 2016 in Review
Commonwealth Equity Services sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 42,715 shares — an estimated $15K sold.
Commonwealth Equity Services first reported a position in RXII in Q2 2013 and held it in 13 quarters. The position peaked at $76K in Q4 2013. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.
- Commonwealth Equity Services reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
- Commonwealth Equity Services sold 42,715 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $15K.
- Commonwealth Equity Services first reported a position in GALENA BIOPHARMA INC COM in Q2 2013 and held it in 13 quarters.
- Commonwealth Equity Services's GALENA BIOPHARMA INC COM position peaked at $76K in Q4 2013.
- 0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.
Based on Commonwealth Equity Services's 13F filing for Q4 2016, filed 1 Feb 2017.